A host of US and Irish firms have won top mandates in what is believed to be the biggest pharmaceuticals deal in history, between Pfizer and Allergan.
Skadden Arps Slate Meagher & Flom is representing Pfizer in its $160bn merger with Allergan, after advising the former on its failed takeover of UK pharmaceuticals company AstraZeneca last year.
Pfizer is also working with Wachtell Lipton Rosen & Katz in the US and A&L Goodbody in Ireland. Cleary Gottlieb Steen & Hamilton and Latham & Watkins are acting for Allergan, with Arthur Cox serving as Irish counsel.
Debevoise & Plimpton is advising financial advisers Guggenheim Securities and Goldman Sachs & Co.
The transaction is due to close in the second half of 2016. The pharmaceuticals industry continues to be active this year, with Allergan recently selling its generics business to Teva Pharmaceutical Industries.
Also on TheLawyer.com:
- Travers Smith’s former private equity head Phil Sanderson talks to The Lawyer about his move to US firm Ropes & Gray
- Shearman and Slaughters winn roles on £3.5bn Liberty Global and Cable & Wireless deal
- Simpson Thacher & Bartlett promotes three in the City, with two in the firm’s capital markets and private funds practice areas
| Featured briefings |
|---|
| Bates Wells Braithwaite – Changes to partnership Gift Aid declarations: the end of donations? |
| Shoosmiths – Black Friday to Cyber Monday: how to ensure you don’t sell out |
| NCTM – Across the EUniverse, Nov 2015: Starbucks, Fiat tax fines; Connected Continent; and more |
| Gateley – No crystal ball required: City Link directors found not guilty |
| Walker Morris – Restatement of the rule against contractual penalties |
